SEATTLE — Using a more robust diagnostic “continuum” for UTIs could improve the diagnosis and treatment of the most common hospital-acquired infection, according to a study.
An international study led by a Rutgers scientist comparing new and older treatments against complicated urinary tract infections has found a new drug combination to be more effective, especially against stubborn, drug-resistant infections.
A phase three clinical trial has identified a more effective combination treatment against urinary tract infections, especially against drug-resistant infections.